Inspirational Teams of Athletes with Diabetes Build Momentum in 2009 with Sponsorship from Long-Acting Insulin Lantus(R) and Rapid-Acting Insulin Apidra(R). Team Type 1 Expands Its Roster, Fielding Five Teams to Spread Personal Messages of Successful Diabetes Management to People Living with Type 1 and Type 2 Diabetes.
BRIDGEWATER, N.J., Feb. 5 /PRNewswire-FirstCall/ -- Sanofi-aventis U.S. announced today its long-acting insulin Lantus(R) (insulin glargine [rDNA origin] injection) and rapid-acting insulin Apidra(R) (insulin glulisine [rDNA origin] injection) will be the primary 2009 sponsors of Team Type 1, a team of amateur and professional athletes living with type 1 diabetes, and Lantus(R) will be the primary sponsor of Team Type 2, an amateur cycling team comprised entirely of members with type 2 diabetes. Sanofi-aventis U.S. has been a sponsor of Team Type 1 since 2007.
Team Type 1, founded by Phil Southerland and Joe Eldridge, both of whom were diagnosed with type 1 diabetes as children, aims to inspire people with diabetes to take a proactive approach to managing their condition by maintaining a healthy diet, exercising regularly, monitoring their blood sugar levels, taking their insulin and other diabetes medications as prescribed, and working closely with their healthcare team.
"When Joe and I formed Team Type 1, we wanted to challenge one another to take control of managing our diabetes, while trying to become the best cyclists we possibly could. Since then, our team has surpassed all of our expectations, and in 2009, with the continued support of sanofi-aventis U.S., Team Type 1 will expand its scope and impact further than ever before," said Phil Southerland, founder and chief executive officer of Team Type 1. "The changes we're making this year will bring us even closer to our life-long goal of competing in the Tour de France."
In 2009, Team Type 1 is expanding its roster and fielding five athletic teams: a men's professional cycling team and a women's professional cycling team, both featuring a mixed roster of riders with and without type 1 diabetes; an elite cycling team for the 2009 Race Across America (RAAM) comprised entirely of riders with type 1 diabetes; and a triathlon team whose members all have type 1 diabetes.
In addition to its type 1 roster in 2009, Team Type 1 will also launch Team Type 2, a team of amateur cyclists living with type 2 diabetes. All members of Team Type 1 with diabetes use Lantus(R), Apidra(R), or a combined treatment regimen of both insulins to help control their blood sugar as part of their overall diabetes treatment plan, which includes regular blood sugar monitoring, diet and exercise.
All members of Team Type 2 manage their blood sugar through their own personal diabetes treatment plan that includes regular blood sugar monitoring, diet, exercise and diabetes medications as prescribed, which, for some members, may include Lantus(R). Diabetes treatment plans should be individualized, and what works for one person may not work for someone else.
Every member of Team Type 1 and Team Type 2 with diabetes has worked with his or her healthcare provider to develop an individual diabetes treatment plan, and they encourage other people living with diabetes to work with their healthcare provider to develop a treatment plan that is right for them.
"Effective diabetes management can be very challenging, especially for competitive athletes, and Team Type 1 is able to do this while competing at the highest level of their sport. Their dedication and achievements encourage others living with diabetes, and even those without it, to be proactive about managing their condition," said Angela Moskow, Vice President, Metabolism Marketing, sanofi-aventis U.S. "As the team expands to include more members this year, including people living with type 2 diabetes, sanofi-aventis U.S. is proud to continue its work with Team Type 1, and the newly-developed Team Type 2, to amplify their voice within the diabetes community as well as the general public."
The teams that make up Team Type 1 are comprised of athletes that may not be typical of a patient with diabetes and individual results may vary. Exercise or activity level may change the way your body uses insulin. Check with your healthcare provider before you start an exercise program because your dose may need to be changed. Also remember to discuss hypoglycemia and the need for regular blood sugar monitoring with your doctor.
In addition to their busy racing schedule, members of Team Type 1 and Team Type 2 will participate in educational speaking engagements across the country to spread awareness of diabetes and encourage others with the disease to take an active role toward managing their condition. Please visit www.Lantus.com for more information about Lantus(R). Please visit www.Apidra.com for more information about Apidra(R).
About Team Type 1
In 2004, friends and team co-founders Phil Southerland and Joe Eldridge set out to prove to themselves and others in the diabetes community that having diabetes doesn't mean you can't achieve your goals. Since then, the team has competed in and twice won the 3,052 mile-long RAAM. In 2008, with the support of a sponsorship from Apidra(R), Team Type 1 fielded two teams: an amateur development level team for the 2008 RAAM comprised of 11 riders, all living with type 1 diabetes, and a professional level racing team featuring a mixed roster of 15 cyclists, including four members with diabetes. In 2009, Team Type 1 is fielding four teams, with a total of 46 athletes (with and without diabetes) competing in professional, amateur level and triathlon competitions. Please visit www.TeamType1.org for more information about Team Type 1.
About Team Type 2
In 2009, with the support of a sponsorship from Lantus(R), Team Type 2, a team of ten amateur cyclists living with type 2 diabetes, was fielded as a new addition to Team Type 1's network of athletes. Team Type 2's long-term goal is to compete in the RAAM, like the Team Type 1 elite team. To help prepare for RAAM, Team Type 2 will participate in several racing events in 2009, primarily the American Diabetes Association's Tour de Cure, a national cycling program designed to raise awareness and funding for diabetes.
Please visit www.TeamType2.org for more information about Team Type 2.